2-(Morpholin-4-yl)-5-(piperidine-1-sulfonyl)benzoic acid, 97%, 100mg

TERT-BUTYL (2-(1H-1,2,3-TRIAZOL-1-YL)ETHYL)CARBAMATE, 95.0%, 500mg

Benzamide, N-[2-[(3S)-3-[[4-hydroxy-4-[5-(2-pyrimidinyl)-2-pyridinyl]cyclohexyl]amino]-1-pyrrolidinyl]-2-oxoethyl]-3-(trifluoromethyl)-, 98%, 1mg

3-(3,4-dimethylphenyl)-2'-thiomethylpropiophenone, 97.0%, 1g

7-Chloro-5-methylpyrazolo[1,5-a]pyrimidine, 97.0%, 5g

2-Amino-3-nitro-6-methoxypyridine, 97.0%, 25g

n-Hexane, min. 95%, for synthesis, 1L, glass packaging

Methyl 5-Bromopyridine-2-carboxylate>98.0%(GC)1g

6-Bromo-2-methyl-pyridine-3-carbaldehyde, 95+%, 250mg

2,4-Dichlorothieno[3,2-d]pyrimidine, 97.0%, 1g

2-(Cyclohex-1-en-1-yl)pyridine, 96.0%, 250mg

cis-Bicyclo[3.1.0]hexan-3-ol, 97.0%, 10g

6-Bromoimidazo[1,2-a]pyridin-2-amine, 97.0%, 1g